Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base

Diabetic Medicine

Volumn 32, Issue 7, 2015, Pages 981-982

  Petrie, M C ^a   Boyle, J G ^a   McKay, G A ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LACTIC ACID; METFORMIN; ANTIDIABETIC AGENT;

CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; EVIDENCE BASED PRACTICE; HUMAN; KIDNEY CLEARANCE; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LETTER; ACIDOSIS, LACTIC; BLOOD; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; PRACTICE GUIDELINE;

ACIDOSIS, LACTIC; DIABETES MELLITUS; GLOMERULAR FILTRATION RATE; GUIDELINE ADHERENCE; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY FAILURE, CHRONIC; METFORMIN;

EID: 84936972128     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12709     Document Type: Letter

References (7)

1. Adam WR, O'Brien RC. A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure. Diabet Med 2014; 31: 1032-1038.
2. Rachmani R, Slavachevski I, Levi Z, Zadok B, Kedar Y, Ravid M. Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications. Eur J Int Med 2002; 13: 428.
3. Ekstrom N, Schioler L, Svensson AM, Eeg-Olofsson K, Miao Jonasson J, Zethelius B et al. Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ 2012; 2: pii: e001076.
4. Lalau JD, Race JM. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999; 20: 377-384.
5. Tucker GT, Casey C, Phillips PJ, Connor H, Ward JD, Woods HF. Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol 1981; 12: 235-246.
6. Royal College of Radiologists Guideline 2013. Prevention of Contrast Induced Acute Kidney Injury (CI-AKI) In Adult Patients, London 2013. Available at http://www.rcr.ac.uk/docs/radiology/pdf/2013_RA_BCIS_RCR.pdf. Last accessed 8 October 2014.
7. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407.